Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a research project in which two standard of care practices will be evaluated to examine the difference in outcomes. The goal is to improve patient care and safety. One group will receive prescriptions for acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), and magnesium. The other group will receive the recommendation to take acetaminophen, NSAIDs, and magnesium as over-the-counter drugs in the same dosage as the prescription group. The same doses and routes for non-opioid medications will be used in both groups.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Prescription Group for acetaminophen, NSAIDs, and magnesium | Active Comparator | Participants will receive prescriptions from the surgical team for non-opioid pain medications to take at home after discharge from surgery. The non-opioid pain medications will be acetaminophen 1000 milligram (mg) four times a day (qid) for 3 days then as needed (prn) pain, ibuprofen 600 mg qid for 3 days then prn, and magnesium oxide 400 mg daily prn pain. |
|
| Over the Counter Group | Active Comparator | Participants will receive a recommendation from the surgical team to take over-the-counter non-opioid pain medications at home after discharge from surgery. The non-opioid pain medications will be acetaminophen 1000 mg qid for 3 days then prn pain, ibuprofen 600 mg qid for 3 days then prn, and magnesium oxide 400 mg daily prn pain. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Prescription by surgical team | Other | The surgical team prescribes medications to the patient |
|
| Measure | Description | Time Frame |
|---|---|---|
| Maximal consumption of acetaminophen and NSAIDs within 3 days after discharge from surgery | Patient report of the number of doses within the first 3 days of the use of both acetaminophen and NSAID at home after discharge from surgery. Patients are anticipated to take up to 4 doses of acetaminophen and NSAIDs per day. Over 3 days, patients would be anticipated to take a maximum of 12 doses. This outcome is a count that ranges from 0 (no doses of acetaminophen plus NSAIDs) to 12. | 3 days following surgery discharge |
| Patient use of acetaminophen within 3 days after discharge from surgery | Patient-reported use of acetaminophen at any point in time within the first 3 days at home after discharge from surgery. | 3 days following surgery discharge |
| Patient use of NSAIDS within 3 days after discharge from surgery | Patient-reported use of NSAIDs at any point in time within the first 3 days at home after discharge from surgery. | 3 days following surgery discharge |
| Patient use of acetaminophen and NSAID with opioid within 3 days after discharge from surgery | Patient-reported use of both acetaminophen and NSAID on every day oral pain medication is taken within the first 3 days at home after discharge from surgery. | 3 days following surgery discharge |
| Delayed acetaminophen and NSAID use as reported at 12-16 days after discharge from surgery | Patient-reported use of acetaminophen and/or NSAIDs in the second week after discharge from surgery. | 12-16 days following surgery discharge |
| Measure | Description | Time Frame |
|---|---|---|
| Patient-reported consumption of opioid pills within 3 days after discharge from surgery | The total amount of opioids consumed over days 0-3 after discharge from surgery will be compared between the two groups. | 3 days following surgery discharge |
| Patient-reported consumption of opioid pills as reported at 12-16 days after discharge from surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Opioid disposal | Patient-reported disposal of opioids after completion of therapy | 3-16 days following surgery discharge |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mark Bicket, MD | University of Michigan | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Michigan | Ann Arbor | Michigan | 48109 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D059787 | Acute Pain |
| ID | Term |
|---|---|
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Recommendation by surgical team | Other | The surgical team recommends the patient to take over-the-counter medications |
|
The total amount of opioids consumed over the second week after discharge from surgery will be compared between the two groups. |
| 12-16 days following surgery discharge |
| Pain intensity at site of surgery 3 days following surgery discharge | This is a one question survey in which the participants are asked to rate the pain at the site of the surgery that best describes the pain from a scale of 0 (no pain) to 10 (pain is the worst). Trends in worst pain intensity over days 0-3 after discharge from surgery will be compared between the two groups. | 3 days following surgery discharge |
| Pain intensity at site of surgery as reported at 12-16 days following surgery discharge | This is a one question survey in which the participants are asked to rate the pain at the site of the surgery that best describes the pain from a scale of 0 (no pain) to 10 (pain is the worst). Trends in worst pain intensity over the second week after discharge from surgery will be compared between the two groups. | 3 days following surgery discharge |
| Medication side effects within 3 days following surgery discharge | Patient report of common analgesic related side effects will be measured using the Medicare symptom checklist. Composite report of any side effect over days 0-3 after discharge from surgery will be compared between the two groups. | 3 days following surgery discharge |
| Patient satisfaction with pain treatment within 3 days following surgery discharge | This is a one question survey in which the participants are asked to rate the satisfaction for pain management with a scale from very dissatisfied to very satisfied. Patient report of overall satisfaction with the postoperative pain treatment over days 0-3 after discharge from surgery will be compared between the two groups. | 3 days following surgery discharge |
| Patient use of magnesium within 3 days after discharge from surgery | Patient-reported use of magnesium at any point in time within the first 3 days at home after discharge from surgery. | 3 days following surgery discharge |
| Delayed magnesium use days as reported at 12-16 days after discharge from surgery | Patient-reported use of magnesium in the second week after discharge from surgery. | 12-16 days following surgery discharge |